Your trusted source for investing success

Tag: CDC

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness.

As quoted in the press release:
According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one

BioCorRx To Launch New Weight Management Program

BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center in Silver Spring, MD.

As quoted in the press release:
 The pilot program is expected to start on October 4, 2017. The Company expects to announce the name of its weight-loss program

Digi International Introduces Patented Data Logger

Digi International (NASDAQ:DGII) has announced the immediate availability of its patented Digi Data Logger, a wireless temperature monitoring and tracking solution for shipping perishable goods.

As quoted in the press release:
The Digi Data Logger, which is attached to the shipment packaging or pallet, or placed in direct contact with the product,

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval

URL: https://investingnews.com/daily/life-science-investing/medical-device-investing/abiomed-announces-peripartum-postpartum-cardiomyopathy-approval/